GenTealModerate to Severe (Novartis Pharmaceutical Corporation)
Welcome to the PulseAid listing for the GenTeal drug offered from Novartis Pharmaceutical Corporation. This pharmaceutical is classified as a HUMAN OTC DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN OTC DRUG drug type category.
LABELER NAME / MANUFACTURER: | Novartis Pharmaceutical Corporation |
NON-PROPRIETARY NAME: | hypromelloses and carboxymethylcellulose sodium |
SUBSTANCE NAME: | HYPROMELLOSES; CARBOXYMETHYLCELLULOSE SODIUM |
TYPE: | HUMAN OTC DRUG |
PHARMA CLASS: | |
ROUTE: | OPHTHALMIC |
DOSAGE FORM: | GEL |
MARKETING CATEGORY NAME: | OTC MONOGRAPH FINAL |
START MARKETING DATE: | 2009-09-14 |
END MARKETING DATE: | 0000-00-00 |
GenTeal Moderate to Severe HUMAN OTC DRUG Details:
Item Description | GenTeal Moderate to Severe from Novartis Pharmaceutical Corporation |
LABELER NAME: | Novartis Pharmaceutical Corporation |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 3; 2.5(mg/mL; mg/mL) |
START MARKETING DATE: | 2009-09-14 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 0078-0425_d84efbd9-c39a-3c0a-5918-2ed77f5cf4fb |
PRODUCT NDC: | 0078-0425 |
APPLICATION NUMBER: | part349 |
Other HYPROMELLOSES; CARBOXYMETHYLCELLULOSE SODIUM Pharmaceutical Manufacturers / Labelers: